Form 6-K SOPHiA GENETICS SA For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq rise in choppy trading as tech steadies, Micron results in focus
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Morgan Stanley Downgrades Sophia Genetics SA (SOPH) to Equalweight, 'Macro Weighs On Qtr/Guide'
August 7, 2024 11:31 AM EDTMorgan Stanley analyst Tejas Savant downgraded Sophia Genetics SA (NASDAQ: SOPH) from Overweight to Equalweight with a price target of $5.00 (from $10.00).
The analyst comments "2Q miss on macro-related biopharma/EMEA headwinds; though leading indicators remain positive, guidance cut reflects achievable 2H ramp despite... More
